Eli Lilly is calling on European countries to make “urgent improvements” to their Alzheimer’s disease diagnostic testing practices just weeks after nabbing a new approval on the continent for its ...
Oct 6 (Reuters) - Eli Lilly (LLY.N), opens new tab will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, ...
Eli Lilly and Company on Monday (October 6, 2025) said it will invest more than $1 billion over the next several years into new contract manufacturing, as well as establish in Hyderabad a new facility ...
Lily-Rose Depp attended Matthieu Blazy’s first collection for Chanel during Paris Fashion Week. Corbis via Getty Images The industry has been abuzz about the recent shake-up amongst creative directors ...
American pharmaceutical giant Eli Lilly and Company is investing over $1 billion (approx Rs 8,900 crore) in India to establish new contract manufacturing facilities, including a significant hub in ...
Shares of Eli Lilly LLY have surged 16% in the past week, driven primarily by positive investor expectations around the broader pharmaceutical sector after Pfizer PFE announced a landmark agreement ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Peter Marks, the ...
Oct 13 (Reuters) - South Africa's Aspen Pharmacare (APNJ.J), opens new tab said on Monday it had secured regulatory approval to market Eli Lilly's (LLY.N), opens new tab blockbuster diabetes and ...
Lily-Rose Depp looked effortlessly chic as she joined her mum Vanessa Paradis at the Chanel Paris catwalk show. The French-American actress, 26, was among the stars who arrived for the Chanel ...
BOSTON--(BUSINESS WIRE)--Kernal Biologics, Inc., a venture-backed therapeutics company developing novel therapeutics to program human cells directly inside the body, today announced its relocation to ...
Hosted on MSN
Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?
Eli Lilly is a leader in weight loss drugs, a market that may reach $95 billion by the end of the decade. Viking Therapeutics is heading toward the finish line with a drug that could compete with ...
Lilly's investment plans in India come at a time when global drugmakers are rushing to bolster US manufacturing capacity after the Trump administration imposed a 100% tariff on imported branded and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback